Genmab to Submit sBLA to FDA for Epcoritamab in Combination with Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma Genmab A/S (Nasdaq: GMAB) has announced its plan to submit a supplemental Biologics License Application (sBLA) to the U.S. Food…
InnoCare’s Next-Generation TRK Inhibitor Zurletrectinib Granted Priority Review by China’s NMPA for NTRK Fusion-Positive Tumors A prominent biopharmaceutical company dedicated to the development of innovative therapies for cancer and autoimmune diseases, announced a major regulatory milestone today. The Center for…
2025 Clinical Trials Outlook: Key Trends in Planned Initiations and Projected Completions A Preview of Trials Planned to Initiate and Estimated to Complete, offering a detailed look into the anticipated global clinical trial landscape for the coming year. Drawing on…
CareDx Posts Strong Q1 2025 Results, Driven by Revenue Growth and Strategic Advancements CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on transplant patient care, has reported financial results for the first quarter ended March 31, 2025. The…
Glaukos Corporation Reports Strong First Quarter 2025 Financial Results, Driven by Record Glaucoma Sales and Sustained Pipeline Progress Glaukos Corporation (NYSE: GKOS), a leading ophthalmic pharmaceutical and medical technology company focused on the development and commercialization of novel therapies for…
ICON Reports First Quarter 2025 Financial Results ICON plc (NASDAQ: ICLR), a leading global clinical research organization (CRO) driven by healthcare intelligence, today announced its financial results for the first quarter of 2025, which ended on March 31, 2025. CEO…
WEX Inc. (NYSE: WEX), a leading global commerce platform that simplifies the business of running a business, today announced its financial results for the first quarter ended March 31, 2025. Despite a modest revenue decline, the company highlighted solid progress…
Adicet Bio Issues Equity Awards to New Employees Pursuant to Nasdaq Inducement Rule 5635(c)(4) Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company advancing gamma delta T cell therapies for cancer, announced that it has granted equity awards to newly hired…
BIOQUAL Announces Retirement of President and CEO Dr. Mark G. Lewis; Dr. Hanne Andersen Elyard Named as Successor BIOQUAL, Inc., a leading provider of in vivo and in vitro preclinical research services, has announced the upcoming retirement of its long-serving…
Creative Solutions in Healthcare Promotes Chelsea Jordan to Vice President of Data Integration and Payroll, Reinforcing Commitment to Innovation and Operational Excellence Creative Solutions in Healthcare, the nation’s largest privately held skilled nursing provider, has announced the promotion of Chelsea…